ASCO 2024: ADC Highlights

ASCO 2024 showcased 200 ADC-related abstracts this year, including 193 clinical and 7 preclinical studies, representing a huge 56% increase from 2023! Our infographic delves into these findings, analysing data by abstract type and trial phase, and presenting the key highlights from the conference.

Download your copy to discover the current leading targets and unlock insights into ADC payloads and conjugation technologies.

ASCO 2024: ADC Highlights Infographic

Covered in this Infographic:

  • Analysis of the 200 ADC-related abstracts presented at ASCO 2024.
  • A breakdown of the top targets currently being studied.
  • A spotlight on the correlation between ADC payloads and conjugation technologies.

To learn more about the infographic and how Beacon ADC can enhance your data needs and provide fast insights, please book a research session below or contact us directly onĀ beacon@hansonwade.com.

You May Also Be Interested In…

What is Beacon?

Beacon is a world leading data analysis tool for preclinical and clinical trial information. With unrivalled granularity of search function, data quality, and exhaustiveness, Beacon provides timely information and gives you confidence to progress your targeted drug therapies to patients.

Learn more about how our clinical trials and drug database solutions can be tailored to your research requirements

Find out more

Menu
Search Icon
Close Icon
Search